{"id":"W7037705081","doi":"","title":"Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2014 - NASDAQ (NASDAQ01) News","year":2014,"lang":"en","type":"other","venue":"","topic":"Fossil Insects in Amber","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Fiscal year; Revenue; Economic forecasting; Productivity","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001852397,0.0009001032,0.0006110869,0.001303446,0.00212354,0.005780285,0.00122083,0.004242175,0.3795787],"category_scores_gemma":[0.003359085,0.0004088589,0.0008025748,0.000754475,0.0007027411,0.001955792,0.001447635,0.003628874,0.2152895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002822917,"about_ca_system_score_gemma":0.007514136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02386785,"about_ca_topic_score_gemma":0.05582063,"domain_scores_codex":[0.9983922,0.00007417749,0.00004423713,0.00009519929,0.001093283,0.0003008696],"domain_scores_gemma":[0.997557,0.0001763122,0.0001354801,0.0000976741,0.001308665,0.0007248067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003064356,0.00002981314,0.00005750532,0.00001320674,0.000001332124,0.00002535131,0.000003345669,0.00001569753,0.00006242315,0.0007508355,0.9902306,0.008779275],"study_design_scores_gemma":[0.00002289982,0.0000280852,0.0005251608,0.00002646129,0.000002367404,0.00003595734,0.00002308352,0.00009253356,0.0002538169,0.0004395962,0.9985437,0.000006222106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0008058592,0.001430411,0.0003984561,0.02118156,0.01013613,0.0001794929,0.008090824,0.001472521,0.9563048],"genre_scores_gemma":[0.001805053,0.0006733984,0.0002181806,0.003232639,0.0006736852,0.00003014783,0.002349124,0.0001711988,0.9908466],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.3795787,"threshold_uncertainty_score":0.8849556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02652789601398922,"score_gpt":0.273885254168001,"score_spread":0.2473573581540117,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}